Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
The American Journal of Gastroenterology|April 13, 2023
Risk of Incident and Fatal Colorectal Cancer After Young-Onset Adenoma Diagnosis: A National Cohort StudyYas Casey, Joshua Demb, Ngozi Enwerem, et al.Journal of Clinical Anesthesia|February 10, 2024
A prospective, observational validation of HRAD±, a novel pediatric affect and cooperation scaleRomy Yun, Daniel Qian, Ellen Wang, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|July 14, 2018
Youth or Young Adults: Which Group Is at Highest Risk for Tobacco Use Onset?Cheryl L Perry, Adriana Pérez, Meagan Bluestein, et al.Gut|June 17, 2010
A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's diseaseIris Dotan, Daniel Rachmilewitz, Stefan Schreiber, et al.Journal of Clinical Anesthesia|November 5, 2021
Development and assessment of an efficient pediatric affect and cooperation scaleKristin M Kennedy, Ellen Wang, Samuel T Rodriguez, et al.Journal of Clinical Anesthesia|September 14, 2023
Virtual reality facilitated exercise improves pain perception: A crossover studySamuel T Rodriguez, Nathan Makarewicz, Ellen Y Wang, et al.American Journal of Physical Medicine & Rehabilitation|June 6, 2024
Virtual Reality Facilitated Exercise Increases Sympathetic Activity and Reduces Pain Perception: A Randomized Crossover StudySamuel T Rodriguez, Nathan Makarewicz, Ellen Y Wang, et al.Annals of Epidemiology|October 18, 2011
Predictors of delayed-stage colorectal cancer: are we neglecting critical demographic information?John W Morgan, Myung Mi Cho, Christine D Guenzi, et al.Journal of Patient Experience|January 8, 2024
Reducing Preoperative Caregiver Anxiety With Virtual Reality: A Pragmatic, Randomized Controlled StudyAhtziri Fonseca, Daniel Qian, Ty Forbes, et al.Inflammatory Bowel Diseases|August 29, 2009
Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitisDaniel C Baumgart, Stephan R Targan, Axel U Dignass, et al.Pageof 9